[1] Siffert W, Rosskorpf D, Siffert G, et al.Association of a human G protein beta 3 subunit variant with hypertension[J].Nat Genet, 1998, 18(1):45-48. [2] Rosskopf D, Manthey I, Habich C, et al.Identification and characterization of G beta 3s2, a novel splice variant of the G-protein beta 3 subunit[J].Biochem J, 2003,371(Pt 1):223-232. [3] Rosskopf D, Manthey I, Siffert W, et al.Identification and ethnic distribution of major haplotypes in the gene GNB3 encoding the G-protein beta3 subunit[J].Pharmacogenetics, 2002, 12(3):209-220. [4] Siffert W, Forster P, J ockel KH, et al.Worldwide ethnic distribution of the G protein beta3 subunit 825T allele and its association with obesity in Caucasian, Chinese, and Black African individuals[J].J Am Soc Nephrol.1999, 10(9):1921-1930. [5] Schunkert H, Hense HW, D¨oring A, et al.Association between a polymorphism in the G protein β3 subunit gene and lower renin and elevated diastolic blood pressure[J]. Hypertension, 1998,32(3):510-513. [6] Hengstenberg C, Schunkert H, Mayer B, et al.Association between a polymorphism in the G protein beta3 subunit gene (GNB3) with arterial hypertension but not with myocardial infarction[J].Cardiovasc Res, 2001, 49(4):820-827. [7] Brand E, Wang JG, Herrmann SM, et al.An epidemiological study of blood pressure and metabolic phenotypes in relation to the G beta3 C825T polymorphism[J].J Hypertens, 2003, 21(4):729-737. [8] Benjafield AV, Jeyasingam CL, Nyholt DR, et al.G-protein beta3 subunit gene (GNB3) variant in causation of essential hypertension[J].Hypertension, 1998,32(6):1094-1097. [9] Brand E, Herrmann SM, Nicaud V, et al.The 825C T polymorphism of the G protein subunit β3 is not related to hypertension[J].Hypertension, 1999,33(5):1175-1178. [10] Kato N, Sugiyama T, MoritaH, et al.G protein beta3 subunit variant and essential hypertension in Japanese[J]. Hypertension, 1999,33(5):1175-1178. [11] Ishikawa K, Imai Y, Katsuya T, et al.Human G-protein beta3 subunit variant is associated with serum potassium and total cholesterol levels but not with blood pressure[J]. Am J Hypertens, 2000, 13(2):140-145. [12] Tozawa Y.G protein beta3 subunit variant:tendency of increasing susceptibility to hypertension in Japanese [J]. Blood Press, 2001, 10(3):131-134. [13] Shioji K, Kokubo Y, Mannami T, et al.Association between hypertension and the alpha-adducin, beta1-adrenoreceptor, and G-protein beta3 subunit genes in the Japanese population:the Suita study[J].Hypertens Res, 2004, 27(1):31-37. [14] Yamamoto M, Abe M, Jin JJ, et al.Association of GNB3 gene with pulse pressure and clustering of risk factors for cardiovascular disease in Japanese[J].Biochem Biophys Res Commun, 2004,316(3):744-748. [15] Izawa H, Yamada Y, Okada T, et al.Prediction of genetic risk for hypertension[J].Hypertension, 2003, 41(5): 1035-1040. [16] Suwazono Y, Okubo Y, Kobayashi E, et al.Lack of association of human G protein beta 3 subunit variant with hypertension in Japanese workers[J].J Hypertens, 2004, 22(3):493-500. [17] 戴书萍, 时景璞, 丁茜, 等.中国东北高血压病高发地区人群中G 蛋白β3 亚单位825C T 多态分析[J]. 遗传学报, 2002, 29(4):294-298. [18] Wang H, Sun N, Gao Y, et al.G protein beta 3 subunit C825T polymorphism and essential hypertension in Chinese[J].Beijing Da Xue Xue Bao, 2003,35(4):423-425. [19] Huang X, Ju Z, Song Y, et al.Lack of association be-tween the G protein beta3 subunit gene and essential hypertension in Chinese:a case-control and a family-based study[J].J Mol Med, 2003, 81(11):729-735. [20] Huang XH, Sun K, Song Y, et al.Association of alphaadducin gene and G protein beta 3 subuint gene with essential hypertension in Chinese[J].Zhonghua Yi Xue Za Zhi, 2007, 87(24):1682-1684. [21] Chen YY, Li GW, Li CM, et al.Association between Gprotein beta3 subunit (GNB (3)) gene C825T polymorphism, hypertension, insulin resistance and obesity[J]. Zhonghua Yi Xue Za Zhi, 2003, 83(14):1229-1232. [22] Turner ST, Schwartz GL, Chapman AB, et al.C825T Polymorphism of the G Protein ? 3 Subunit and Antihypertensive Response to a Thiazide Diuretic[J].Hypertension, 2001,37(2):739-743. [23] Schelleman H, Stricker BH, Verschuren WM, et al.Interactions between five candidate genes and antihypertensive drug therapy on blood pressure[J].Pharmacogenomics J, 2006, 6(1):22-26. [24] 应剑, 冯雁, 黄爱群, 等.G 蛋白β3 亚基基因(GNB3) C825T多态性影响硝苯地平控释片15 d 降压幅度[J].中国药理学通报, 2003, 19(9):1013-1016. [25] Matayoshi T, Kamide K, Takiuchi S, et al.The thiazidesensitive Na +-Cl-cotransporter gene, C1784T, and adrenergic receptor-beta3 gene, T727C, may be gene polymorphisms susceptible to the antihypertensive effect of thiazide diuretics[J].Hypertens Res, 2004, 27(11):821-833. [26] Geller F, Reichwald K, Dempfle A, et al.Melanocortin-4 receptor gene variant i103 is negatively associated with obesity[J].Am J Hum Genet, 2004, 74(3):572-581. [27] Nǜrnberger J, Dammer S, Mitchell A, et al.Effect of the C825T polymorphism of the G protein beta 3 subunit on the systolic blood pressure-lowering effect of clonidine in young, healthy male subjects[J].Clin Pharmacol Ther, 2003, 74(1):53-60. [28] Beige J, Hohenbleicher H, Distler A, et al.G-protein beta3 subunit C825T variant and ambulatory blood pressure in essential hypertension[J].Hypertension, 1999,33(4): 1049-1051. [29] Mitchell A, Rushentsova U, Siffert W, et al.The angiotensin II receptor antagonist valsartan inhibits endothelin 1-induced vasoconstriction in the skin microcirculation in humans in vivo:Influence of the G protein β3 subunit (GNB3) C825T polymorphism[J].Clin Pharmacol Ther, 2006, 79(3):274-281. [30] Torfgard K, Ahlner J, Axelsson KL, et al.Relaxation of bovine mesenteric arteries by glyceryl trinitrate and other nitrocompounds: evidence for partly different mechanisms of action[J].Pharmacol Toxicol, 1990, 67(3):216-221. [31] Ahlner J, Axelsson KL, Ekstram-Ljusegren M, et al.Relaxation of bovine mesenteric artery induced by gly ceryl trinitrate is attenuated by pertussis toxin[J].Pharmacol Toxicol, 1988, 62(3):155-158. [32] Mitchell A, Lǜckebergfeld B, Bǜhrmann S, et al.Venous response to nitroglycerin is enhanced in young, healthy carriers of the 825T allele of the G protein β3 subunit gene (GNB3)[J].Clin Pharmacol Ther, 2003, 74(5):499-504. |